Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024,
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024,
Non-invasive health diagnostics are on the rise, and fingerprint testing technology is at the forefront. This article explores the history
NEW YORK, April 11, 2024 – Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company
NEW YORK, February 28, 2024 – Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company
NEW YORK, February 16, 2024 – Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company
Year-over-year revenue increased 114% for the fiscal second quarter and 337% for the six-months ending December 31, 2023. Expanded into
Year-over-year unaudited revenue increased 114% for the fiscal second quarter and 337% for the six months ended December 31, 2023
Customers identify in-house control, project flexibility, productivity, and cost reductions as key business benefits of fingerprint drug testing
Intelligent Fingerprinting to be used for in-house drug testing, enabling full testing control to support new James Jones drug and
Construction logistics, security, and support specialist selects Intelligent Fingerprinting Drug Screening System to simplify and speed up workplace drug testing
Intelligent Bio Solutions Inc. today announced that Robinson Brothers, one of the UK’s largest independent chemical manufacturers, is now using
Intelligent Bio Solutions Inc. today announced that it has received National Association of Testing Authorities (NATA) accreditation for its Intelligent Fingerprinting Drug
Australia, known for its thriving economy and competitive job market, is experiencing an alarming increase in substance abuse among white-collar
Intelligent Fingerprinting Drug Screening System is expected to reduce P&O Ferries’ overall drug testing costs by 90%. Easy-to-use, hygienic fingerprint
Since 2001, Titan has secured its spot as Australasia’s leading specialist material handling company, providing state-of-the-art lifting equipment and labor to the